Probiotics, prebiotics and immunomodulation of gut mucosal defences: Homeostasis and immunopathology

Nutrients

Volumn 5, Issue 6, 2013, Pages 1869-1912

  Hardy, Holly ^a   Harris, Jennifer ^a   Lyon, Eleanor ^a   Beal, Jane ^a   Foey, Andrew D ^a  

^a UNIVERSITY OF PLYMOUTH   (United Kingdom)

Author keywords

Activation; Cancer; Cytokines; Hypersensitivity; Immunomodulation; Inflammatory bowel disease; Prebiotics; Probiotics; Synbiotics; Tolerance

Indexed keywords

IMMUNOGLOBULIN A; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 23; INTERLEUKIN 35; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; MUCIN; POLYPEPTIDE ANTIBIOTIC AGENT; PREBIOTIC AGENT; PROBIOTIC AGENT; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ALLERGIC REACTION; ALLERGY; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; ANTINEOPLASTIC ACTIVITY; BACTERIAL FLORA; BACTERIAL STRAIN; BIFIDOBACTERIUM ANIMALIS; BIFIDOBACTERIUM BIFIDUM; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELIAC DISEASE; COLORECTAL CANCER; COMMENSALISM; CROHN DISEASE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE ASSOCIATION; DRUG MECHANISM; ENTERITIS; GASTROINTESTINAL MUCOSA; HOMEOSTASIS; HUMAN; HYPERSENSITIVITY; IMMUNOGLOBULIN PRODUCTION; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOPATHOLOGY; IMMUNOSTIMULATION; INTESTINE EPITHELIUM CELL; INTESTINE FLORA; LACTOBACILLUS; LYMPHOCYTE DIFFERENTIATION; MUCUS SECRETION; NATURAL KILLER CELL; NONHUMAN; PROTEIN EXPRESSION; REVIEW; SACCHAROMYCES BOULARDII; SYMBIOSIS; TH2 CELL; ULCERATIVE COLITIS; XENOBIOTIC METABOLISM;

EID: 84878432985     PISSN: 20726643     EISSN: None     Source Type: Journal    
DOI: 10.3390/nu5061869     Document Type: Review

References (245)

1. FAO/WHO. Guidelines for the Evaluation of Probiotics in Food, 2002. Available online: http://ftp.fao.org/es/esn/food/wgreport2.pdf (accessed on 1 May 2013).
2. Maurice, C.F.; Haiser, H.J.; Turnbaugh, P.J. Xenobiotics shape the physiology and gene expression of the active human gut microbiome. Cell 2013, 152, 39-50.
3. Bentley, R.; Meganathan, R. Biosynthesis of vitamin K (menaquinone) in bacteria. Mircobiol. Rev. 1982, 46, 241-280.
4. Nilsson, A.C.; Östman, E.M.; Holst, J.; Björk, I.M. Including indigestible carbohydrates in the evening meal of healthy subjects improves glucose tolerance, lowers inflammatory marks, and increases satiety after subsequent standardized breakfast. J. Nutr. 2008, 138, 732-739.
5. Matsumoto, M.; Ishige, A.; Yazawa, Y.; Kondo, M.; Muramatsu, K.; Watanabe, K. Promotion of intestinal peristalsis by Bifidobacterium spp. Capable of hydrolysis sennosides in mice. PLoS One 2012, 7, e31700.
6. Candela, M.; Perna, F.; Carnevali, P.; Vitali, B.; Ciati, R.; Gionchetti, P.; Rizzello, F.; Campieri, M.; Brigidi, P. Interaction of probiotic Lactobacillus and Bifidobacterium strains with human intestinal epithelial cells: Adhesion properties, competition against enteropathogens and modulation of IL-8 production. Int. J. Food Microbiol. 2008, 125, 286-292.
7. Mazmanian, S.K.; Lui, C.; Tzianaboz, A.O.; Kasper, D.L. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 2005, 122, 107-118.
8. Zschüttig, A.; Zimmermann, K.; Blom, J.; Goesmann, A.; Pöhlmann, C.; Gunzer, F. Identification and characterisation of Microcin S, a new antibacterial peptide produced by probiotic Escherichia coli G3/10. PLoS One 2012, 7, e33351.
9. Gibson, G.R.; Roberfroid, M.B. Dietary modulation of the human colonic microbiota: Introducing the concept of prebiotics. J. Nutr. 1995, 125, 1401-1412.
10. Van Zanten, G.C.; Knudsen, A.; Röytiö, H.; Forssten, S.; Lawther, M.; Blennow, A.; Lahtinen, S.J.; Jakobsen, M.; Svensson, B.; Jespersen, L. The effect of selected synbiotics on microbial composition and short-chain fatty acid production in model system of the human colon. PLoS One 2012, 7, e47212.
11. Knol, J.; Scholtens, P.; Kafka, C.; Steenbakkers, J.; Gro, S.; Helm, K.; Klarczyk, M.; Schöpfer, H.; Böckler, H.M.; Wells, J. Colon microflora in infants fed formula with galacto- and fructo- oligosaccharides: More like breast-fed infants. J. Pediatr. Gastroenterol. Nutr. 2005, 40, 36-42.
12. Holscher, H.D.; Faust, K.L.; Czerkies, L.A.; Litov, R.; Ziegler, E.E.; Lessin, H.; Hatch, T.; Sun, S.; Tappenden, K.A. Effects of prebiotic-containing infant formula on gastrointestinal tolerance and fecal microbiota in a randomized controlled trial. JPEN J. Parenter. Enteral Nutr. 2012, 36, 95S-105S.
13. Roberfroid, M.; Gibson, G.R.; Hoyles, L.; McCartney, N.L.; Rastall, R.; Rowland, I.; Wolvers, D.; Watzl, B.; Szajewska, H.; Stahl, B.; et al. Prebiotic effects metabolic and health benefits. Br. J. Nutr. 2010, 104, S1-S63.
14. Yazawa, K.; Imai, K.; Tamura, Z. Oligosaccharides and polysaccharides specifically utilizable by bifidobacteria. Chem. Pharm. Bull. 1978, 26, 3306-3311.
15. Mitsuoak, T.; Hidaka, H.; Eida, T. Effect of fructo-oligosaccharides on intestinal microflora. Nahrung 1987, 31, 427-436.
16. Nepelska, M.; Cultrone, A.; Béguet-Crespel, F.; Le Roux, K.; Doré, J.; Arulampalam, V.; Blottière, H.M. Butyrate produced by commensal bacteria potentiates phorbol esters induced AP-1 response in human intestinal epithelial cells. PLoS One 2012, 7, e52869.
17. Ohigashi, S.; Sudo, K.; Kobayashi, D.; Takahashi, O.; Takahashi, T.; Asahara, T.; Nomoto, K.; Onodera, H. Changes of the intestinal microbiota, short chain fatty acids and fecal pH in patients with colorectal cancer. Digest. Dis. Sci. 2013, in press.
18. Whitman, W.B.; Coleman, D.C.; Wiebe, W.J. Prokaryotes: The unseen majority. Proc. Natl. Acad. Sci. USA 1998, 95, 6578-6583.
19. Bäckhed, F.; Ley, R.E.; Sonnenburg, J.L.; Peterson, D.A.; Gordon, J.I. Host-bacterial mutualism in the human intestine. Science 2005, 307, 1915-1920.
20. Gill, S.R.; Pop, M.; DeBoy, R.T.; Eckburg, P.B.; Turnbaugh, P.J.; Samuel, B.S.; Gordon, J.I.; Relman, D.A.; Fraser-Liggett, C.M.; Nelson, K.E. Metagenomic analysis of the human distal gut microbiome. Science 2006, 312, 1355-1359.
21. Eckburg, P.B.; Bik, E.M.; Bernstein, C.N.; Purdom, E.; Dethlefsen, L.; Sargent, M.; Gill, S.R.; Nelson, K.E.; Relman, D.A. Diversity of the human intestinal microbial flora. Science 2005, 308, 1635-1638.
22. Qin, J.; Li, R.; Raes, J.; Arumugam, M.; Burgdorf, K.S.; Manichanh, C.; Nielsen, T.; Pons, N.; Levenez, F.; Yamada, T.; et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010, 464, 59-65.
23. Penders, J.; Thijs, C.; Vink, C.; Stelma, F.F.; Snijders, B.; Kummeling, I.; van den Brandt, P.A.; Stobberingh, E.E. Factors influencing the composition of the intestinal microbiota in early infancy. Paediatrics 2006, 118, 511-521.
24. Biasucci, G.; Benenati, B.; Morelli, L.; Bessi, E.; Boehm, G. Cesarean delivery may affect the early biodiversity of intestinal bacteria. J. Nutr. 2008, 138, 1796S-1800S.
25. Huurre, A.; Kalliomäki, M.; Rautava, S.; Rinne, M.; Salminen, S.; Isolauri, E. Mode of delivery-Effects on gut microbiota and humoral immunity. Neonatology 2008, 93, 236-240.
26. Liao, Y.; Jiang, R.; Lönnerdal, B. Biochemical and molecular impacts of lactoferrin on small intestinal growth and development. Biochem. Cell Biol. 2012, 90, 476-484.
27. Martín, R.; Langa, S.; Reviriego, C.; Jimínez, E.; Marín, M.L.; Xaus, J.; Fernández, L.; Rodríguez, J.M. Human milk is a source of lactic acid bacteria for the infant gut. J. Pediatr. 2003, 143, 754-758.
28. Martín, R.; Jiménez, E.; Heilig, H.; Fernández, L.; Marín, M.L.; Zoetendal, E.G.; Rodríguez, J.M. Isolation of bifidobacteria from breast milk and assessment of the bifidobacterial population by PCR-denaturing gradient gel electrophoresis and quantitative real-time PCR. Appl. Environ. Microbiol. 2009, 74, 965-969.
29. Albesharat, R.; Ehrmann, M.A.; Korakli, M.; Yazaji, S.; Vogel, R.F. Phenotypic and genotypic analyses of lactic acid bacteria in local fermented food, breast milk and faeces of mothers and their babies. Syst. Appl. Microbiol. 2011, 34, 148-155.
30. Martin, R.; Langa, S.; Reviriegoa, C.; Jiméneza, E.; Marina, M.L.; Olivaresb, M.; Bozab, J.; Jiménezb, J.; Fernándeza, L.; Xausb, J.; et al. The commensal microflora of human milk: New perspectives for food bacteriotherapy and probiotics. Trends Food Sci. Technol. 2004, 15, 121-127.
31. Garrido, D.; Nwosu, C.; Ruiz-Moyano, S.; Aldredge, D.; German, J.B.; Lebrilla, C.B.; Mills, D.A. Endo-β-N-acetylglucosaminidases from infant gut-associated bifidobacteria release complex N-glycans from human milk glycoproteins. Mol. Cell. Proteomics 2012, 11, 775-785.
32. Yolken, R.H.; Peterson, J.A.; Vonderfecht, S.L.; Fouts, E.T.; Midthun, K.; Newburg, D.S. Human milk mucin inhibits rotavirus replication and prevents experimental gastroenteritis. J. Clin. Invest. 1992, 90, 1984-1991.
33. Dobson, A.; Crispie, F.; Rea, M.C.; O'Sullivan, O.; Casey, P.G.; Lawlor, P.G.; Cotter, P.D.; Ross, P.; Gardiner, G.E.; Hill, C. Fate and efficacy of lacticin 3147-producing Lactococcus lactis in the mammalian gastrointestinal tract. FEMS Microbiol. Ecol. 2011, 76, 602-614.
34. Yu, Z.T.; Chen, C.; Kling, D.E.; Liu, B.; McCoy, J.M.; Merighi, M.; Heidtman, M.; Newburg, D.S. The principal fucosylated oligosaccharides of human milk exhibit prebiotic properties on cultured infant microbiota. Glycobiology 2013, 23, 169-177.
35. Eggesbø, M.; Moen, B.; Peddada, S.; Baird, D.; Rugtveit, J.; Midtvedt, T.; Bushel, P.R.; Sekelja, M.; Rudi, K. Development of gut microbiota in infants not exposed to medical interventions. APMIS 2011, 119, 17-35.
36. Savino, F.; Roana, J.; Mandras, N.; Tarasco, V.; Locatelli, E.; Tullio, V. Faecal microbiota in breast-fed infants after antibiotic therapy. Acta Paediatr. 2011, 100, 75-78.
37. Bartizal, K.F.; Wostmann, B.S.; Wagner, M. Distribution and effects of a defined six-member murine derived microflora in gnotobiotic gerbils. Appl. Environ. Microbiol. 1984, 47, 746-751.
38. Pollard, M.; Sharon, N. Responses of the Peyer's patches in germ-free mice to antigenic stimulation. Infect. Immun. 1970, 2, 96-100.
39. Williams, A.M.; Probert, C.S.; Stepankova, R.; Tlaskalova-Hogenova, H.; Phillips, A.; Bland, P.W. Effects of microflora on the neonatal development of gut mucosal T cells and myeloid cells in the mouse. Immunology 2006, 119, 470-478.
40. Yamamoto, M.; Yamaguchi, R.; Munakata, K.; Takashima, K.; Nishiyama, M.; Hioki, K.; Ohnishi, Y.; Nagasaki, M.; Imoto, S.; Miyano, S.; et al. A microarray analysis of gnotobiotic mice indicating that microbial exposure during the neonatal period plays an essential role in immune system development. BMC Genomics 2012, 13, 335.
41. Rhee, K.; Sethupathi, P.; Dirks, A.; Lanning, D.K.; Knight, K.L. Role of commensal bacteria in development of gut-associated lymphoid tissues and preimmune antibody repertoire. J. Immunol. 2004, 172, 1118-1124.
42. Russell, S.L.; Gold, M.J.; Willing, B.P.; Thorson, L.; McNagny, K.M.; Finlay, B.B. Perinatal antibiotic treatment affects murine microbiota, immune responses and allergic asthma. Gut Microbes 2013, 4, 158-164.
43. King, C.; Sarvetnick, N. The incidence of type-1 diabetes in NOD mice is modulated by restricted flora not germ-free conditions. PLoS One 2011, 6, e17049.
44. Ochoa-Repáraz, J.; Mielcarz, D.W.; Wang, Y.; Begum-Haque, S.; Dasgupta, S.; Kasper, D.L.; Kasper, L.H. A polysaccharide from the human commensal Bacteroides fragilis protects against CNS demyelinating disease. Mucosal Immunol. 2010, 3, 487-495.
45. Strachan, D.P. Hay fever, hygiene, and household size. Br. Med. J. 1989, 299, 1259-1260.
46. Aumeunier, A.; Grela, F.; Ramadan, A.; Pham Van, L.; Bardel, E.; Gomez Alcala, A.; Jeannin, P.; Akira, S.; Bach, JF.; Thieblemont, N. Systemic Toll-like receptor stimulation suppresses experimental allergic asthma and autoimmune diabetes in NOD mice. PLoS One 2010, 5, e11484.
47. Gross, F.; van der Meulen, J.; Snel, J.; van der Meer, R.; Kleerebezem, M.; Niewold, T.V.; Hulst, M.M.; Smiths, M.A. Mannose-specific interaction of Lactobacillus plantarum with porcine jejunal epithelium. FEMS Immunol. Med. Microbiol. 2008, 54, 215-223.
48. Wilson, K.H.; Perini, F. Role of competition for nutrients in suppression of Clostridium difficile by the colonic microflora. Infect. Immun. 1988, 56, 2610-2614.
49. Maltby, R.; Leatham-Jensen, M.P.; Gibson, T.; Cohen, P.S.; Conway, T. Nutritional basis for colonization resistance by human commensal Escherichia coli strains HS and nissle 1917 against E. coli O157:H7 in the mouse intestine. PLoS One 2013, 8, e53957.
50. Resta-Lenert, S.; Barrett, K.E. Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC). Gut 2003, 52, 988-997.
51. Cario, E.; Gerken, G.; Podolsky, D.K. Toll-like receptor 2 enhances ZO-1-associated intestinal epithelial barrier integrity via protein kinase C. Gastroenterology 2004, 127, 224-238.
52. Petrof, E.O.; Kojima, K.; Ropeleski, M.J.; Tao, Y.; de Simone, C.; Chang, E.B. Probiotics inhibit nuclear factor kappaB and induce heat shock proteins in colonic epithelial cells through proteasome inhibition. Gastroenterology 2004, 127, 1474-1487.
53. Tao, Y.; Drabik, K.A.; Waypa, T.S.; Musch, M.W.; Alverdy, J.C.; Schneewind, O.; Chang, E.B.; Petrof, E.O. Soluble factors from Lactobacillus GG activate MAPKs and induce cytoprotective heat shock proteins in intestinal epithelial cells. Am. J. Physiol. Cell Physiol. 2006, 290, C1018-C1030.
54. Park, H.S.; Cho, S.G.; Kim, C.K.; Hwang, H.S.; Noh, K.T.; Kim, M.S.; Huh, S.H.; Kim, M.J.; Ryoo, K.; Kim, E.K.; et al. Heat shock protein hsp72 is a negative regulator of apoptosis signal-regulating kinase 1. Mol. Cell Biol. 2002, 22, 7721-7730.
55. Liu, T.S.; Musch, M.W.; Sugi, K.; Walsh-Reitz, M.M.; Ropeleski, M.J.; Hendrickson, B.A.; Pothoulakis, C.; Lamont, J.T.; Chang, E.B. Protective role of HSP72 against Clostridium difficile toxin A-induced intestinal epithelial cell dysfunction. Am. J. Physiol. Cell Physiol. 2003, 284, C1073-1082.
56. Gendler, S.J.; Spicer, A.P. Epithelial mucin genes. Annu. Rev. Physiol. 1995, 57, 607-634.
57. Van Tassell, M.L.; Miller, M.J. Lactobacillus adhesion to mucus. Nutrients 2011, 3, 613-636.
58. Mack, D.R.; Michail, S.; Wei, S.; McDougall, L.; Hollingsworth, M.A. Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am. J. Physiol. 1999, 276, G941-G950.
59. Caballero-Franco, C.; Keller, K.; de Simone, C.; Chadee, K. The VSL#3 probiotic formula induces mucin gene expression and secretion in colonic epithelial cells. Am. J. Physiol. Gastrointest. Liver Physoil. 2007, 292, 315-322.
60. Perez-Vilar, J.; Hill, R.L. The structure and assembly of secreted mucins. J. Biol. Chem. 1999, 274, 31751-31754.
61. Katayama, T.; Fujita, K.; Yamamoto, K. Novel bifidobacterial glycosides action on sugar chains of mucin glycoproteins. J. Biosci. Bioeng. 2005, 99, 457-465.
62. Kiyohara, M.; Nakatomi, T.; Kurihara, S.; Fushinobu, S.; Suzuki, H.; Tanaka, T.; Shoda, S.; Kitaoka, M.; Katayama, T.; Yamamoto, K.; et al. α-N-acetylgalactosaminidase from infant-associated bifidobacteria belonging to novel glycoside hydrolase family 129 is implicated in alternative mucin degradation pathway. J. Biol. Chem. 2012, 287, 693-700.
63. Biesbrock, A.R.; Reddy, M.S.; Levine, M.J. Interaction of a salivary mucin-secretory immunoglobulin A complex with mucosal pathogens. Infect. Immun. 1991, 59, 3492-3497.
64. Rautava, S.; Arvilommi, H.; Isolaur, E. Specific probiotics in enhancing maturation of IgA responses in formula-fed infants. Pediatr. Res. 2006, 60, 221-224.
65. Rodrigues, A.C.; Cara, D.C.; Fretez, S.H.; Cunha, F.Q.; Vieira, E.C.; Nicoli, J.R.; Vieira, L.Q. Saccharomyces boulardii stimulates sIgA production and the phagocytic system of gnotobiotic mice. J. Appl. Microbiol. 2000, 89, 404-414.
66. He, B.; Xu, W.; Santini, P.A.; Polydorides, A.D.; Chiu, A.; Estrella, J.; Shan, M.; Chadburn, A.; Villanacci, V.; Plebani, A.; et al. Intestinal bacteria trigger T cell-independent immunoglobulin A2 class switching by inducing epithelial-cell secretion of the cytokine APRIL. Immunity 2007, 26, 812-826.
67. Shang, L.; Fukata, M.; Thirunarayanan, N.; Martin, A.P.; Arnaboldi, P.; Maussang, D.; Berin, C.; Unkeless, J.C.; Mayer, L.; Abreu, M.T.; et al. Toll-like receptor signaling in small intestinal epithelium promotes B-cell recruitment and IgA production in lamina propria. Gastroenterology 2008, 135, 529-538.
68. Reséndiz-Albor, A.A.; Reina-Garfias, H.; Rojas-Hernández, S.; Jarillo-Luna, A.; Rivera-Aguilar, V.; Miliar-García, A.; Campos-Rodríguez, R. Regionalization of pIgR expression in the mucosa of mouse small intestine. Immunol. Lett. 2010, 128, 59-67.
69. Gillor, O.; Giladi, I.; Riley, M.A. Persistance of colicinogenic Escherichia coli in the mouse gastrointestinal tract. BMC Microbiol. 2009, 9, 165.
70. Tong, Z.; Zhou, L.; Li, J.; Kuang, R.; Lin, Y.; Ni, L. An in vitro investigation of Lactococcus lactis antagonising cariogenic bacterium Streptococcus mutans. Arch. Oral Biol. 2012, 57, 376-382.
71. Corr, S.C.; Li, Y.; Riedel, C.U.; O'Toole, P.W.; Hill, C.; Gahan, C.G. Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118. Proc. Natl. Acad. Sci. USA 2007, 104, 7617-7621.
72. Meijerink, M.; van Hemert, S.; Taverne, N.; Wels, M.; de Vos, P.; Bron, P.A.; Savelkoul, H.F.; van Bilsen, J.; Kleerebezem, M.; Wells, J.M. Identification of genetic loci in Lactobacillus plantarum that modulate the immune response of dendritic cells using comparative genome hybridization. PLoS One 2010, 5, e10632.
73. Casey, P.G.; Gardiner, G.E.; Casey, G.; Bradshaw, B.; Lawlor, P.G.; Lynch, P.B.; Leonard, F.C.; Stanton, C.; Ross, R.P.; Fitzgerald, G.F.; et al. A five-strain probiotic combination reduces pathogen shedding and alleviates disease signs in pigs challenged with Salmonella enterica Serovar Typhimurium. Appl. Envrion. Microb. 2007, 73, 1858-1863.
74. Dabour, N.; Zihler, A.; Kheadr, E.; Lacroix, C.; Fliss, I. In vivo study on the effectiveness of pediocin PA-1 and Pediococcus acidilactici UL5 at inhibiting Listeria monocytogenes. Int. J. Food Microbiol. 2009, 133, 225-233.
75. Rea, M.C.; Dobson, A.; O'Sullivan, O.; Crispie, F.; Fouhy, F.; Cotter, P.D.; Shanahan, F.; Kiely, B.; Hill, C.; Ross, R.P. Effect of broad- and narrow-spectrum antimicrobials on Clostridium difficile and microbial diversity in a model of the distal colon. Proc. Natl. Acad. Sci. USA 2011, 108, 4639-4644.
76. McAuliffe, O.; Ryan, M.P.; Ross, R.P.; Hill, C.; Breeuwer, P.; Abee, T. Lacticin 3147, a broad-spectrum bacteriocin which selectively dissipates the membrane potential. Appl. Environ. Microbiol. 1998, 64, 439-445.
77. Ganz, T.; Selsted, M.E.; Szklarek, D.; Harwig, S.S.; Daher, K.; Bainton, D.F.; Lehrer, R.I. Defensins. Natural peptide antibiotics of human neutrophils. J. Clin. Invest. 1985, 76, 1427-1435.
78. Selsted, M.E.; Harwig, S.S.; Ganz, T.; Schilling, J.W.; Lehrer, R.I. Primary structures of three human neutrophil defensins. J. Clin. Invest. 1985, 76, 1436-1439.
79. Ayabe, T.; Satchell, D.P.; Pesendorfer, P.; Tanabe, H.; Wilson, C.L.; Hagen, S.J.; Ouellette, A.J. Activation of Paneth cell alpha-defensins in mouse small intestine. J. Biol. Chem. 2002, 277, 5219-5228.
80. Möndel, M.; Schroeder, B.O.; Zimmermann, K.; Huber, H.; Nuding, S.; Beisner, J.; Fellermann, K.; Stange, E.F.; Wehkamp, J. Probiotic E. coli treatment mediates antimicrobial human beta-defensin synthesis and fecal excretion in humans. Mucosal Immunol. 2009, 2, 166-172.
81. Schlee, M.; Wehkamp, J.; Altenhoefer, A.; Oelschlaeger, T.A.; Stange, E.F.; Fellermann, K. Induction of human beta-defensin 2 by the probiotic Escherichia coli Nissle 1917 is mediated through flagellin. Infect. Immun. 2007, 75, 2399-2407.
82. Schlee, M.; Harder, J.; Köten, B.; Stange, E.F.; Wehkamp, J.; Fellermann, K. Probiotic lactobacilli and VSL#3 induce enterocyte beta-defensin 2. Clin. Exp. Immunol. 2008, 151, 528-535.
83. Hugo, A.A.; de Antoni, G.L.; Pérez, P.F. Lactobacillus delbrueckii subsp lactis (strain CIDCA 133) resists the antimicrobial activity triggered by molecules derived from enterocyte-like Caco-2 cells. Lett. Appl. Microbiol. 2010, 50, 335-340.
84. Yang, D.; Chertov, O.; Bykovskaia, S.N.; Chen, Q.; Buffo, M.J.; Shogan, J.; Anderson, M.; Schröder, J.M.; Wang, J.M.; Howard, O.M.; Oppenheim, J.J. Beta-defensins: Linking innate and adaptive immunity through dendritic and T cell CCR6. Science 1999, 286, 525-528.
85. Ismail, A.S.; Severson, K.M.; Vaishnava, S.; Behrendt, C.L.; Yu, X.; Benjamin, J.L.; Ruhn, K.A.; Hou, B.; DeFranco, A.L.; Yarovinsky, F.; et al. γδ intraepithelial lymphocytes are essential mediators of host-microbial homeostasis at the intestinal mucosal surface. Proc. Natl. Acad. Sci. USA 2011, 108, 8743-8748.
86. Li, Z.; Zhang, C.; Zhou, Z.; Zhang, J.; Zhang, J.; Tian, Z. Small intestinal CD8+TCRγδ+ intraepithelial lymphocytes (iIELs) are involved in bacterial clearance during Salmonella typhimurium infection. Infect. Immun. 2012, 80, 565-574.
87. Roselli, M.; Finamore, A.; Nuccitelli, S.; Carnevali, P.; Brigidi, P.; Vitali, B.; Nobili, F.; Rami, R.; Garaguso, I.; Mengheri, E. Prevention of TNBS-induced colitis by different Lactobacillus and Bifidobacterium strains is associated with as expansion of γδT and regulatory T cells of intestinal intraepithelial lymphocytes. Inflamm. Bowel Dis. 2009, 15, 1526-1536.
88. Li, Y.; Innocentin, S.; Withers, D.R.; Roberts, N.A.; Gallagher, A.R.; Grigorieva, E.F.; Wilhelm, C.; Veldhoen, M. Exogenous stimuli maintain intraepithelial lymphocytes via Aryl hydrocarbon receptor activation. Cell 2011, 147, 629-640.
89. Schulz, V.J.; Smit, J.J.; Willemsen, K.J.; Fiechter, D.; Hassing, I.; Bleumink, R.; Boon, L.; van den Berg, M.; van Duursen, M.B.M.; Pieters, R.H.H. Activation of the aryl hydrocarbon receptor suppresses sensitization in a mouse peanut allergy model. Toxicol. Sci. 2011, 123, 491-500.
90. Van Baarlen, P.; Troost, F.J.; van Hemert, S.; van der Meer, C.; de Vos, W.M.; de Groot, P.J.; Hooiveld, G.J.E.J.; Brummer, R.M.; Kleerebezem, M. Differential NF-B pathways induction by Lactobacillus plantarum in the duodenum of healthy humans correlating with immune tolerance. Proc. Natl. Acad. Sci. USA 2009, 106, 2371-2376.
91. Hershberg, R.M.; Cho, D.H.; Youakim, A.; Bradley, M.B.; Lee, J.S.; Framson, P.E.; Nepom, G.T. Highly polarized HLA class II antigen processing and presentation by human intestinal epithelial cells. J. Clin. Invest. 1998, 102, 792-803.
92. Snoeck, V.; Goddeeris, B.; Cox, E. The role of enterocytes in the intestinal barrier function and antigen uptake. Microbes Infect. 2005, 7, 997-1004.
93. Bloom, S.; Simmons, D.; Jewell, D.P. Adhesion molecules intercellular adhesion mole-1 (ICAM-1), ICAM-3 and B7 are not expressed by epithelium in normal or inflamed colon. Clin. Exp. Immunol. 1995, 101, 157-163.
94. Rimoldi, M.; Chieppa, M.; Salucci, V.; Avogadri, F.; Sonzogni, A.; Sampietro, G.M.; Nespoli, A.; Viale, G.; Allavena, P.; Rescigno, M. Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells. Nat. Immunol. 2005, 6, 507-514.
95. Taylor, B.C.; Zaph, C.; Troy, A.E.; Du, Y.; Guild, K.J.; Comeau, M.R.; Artis, D. TSLP regulates intestinal immunity and inflammation in mouse models of helminth infection and colits. J. Exp. Med. 2009, 206, 655-667.
96. Niess, J.H.; Brand, S.; Gu, X.; Landsman, L.; Jung, S.; McCormick, B.A.; Vyas, J.M.; Boes, M.; Ploegh, H.L.; Fox, J.G.; et al. CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science 2005, 307, 254-258.
97. Chieppa, M.; Rescigno, M.; Huang, A.Y.C.; Germain, R.N. Dynamic imaging of dendritic cell extension into the small bowel lumen in response to epithelial cell TLR engagement. J. Exp. Med. 2006, 203, 2841-2852.
98. Rescigno, M.; Urbano, M.; Valzasina, B.; Francolini, M.; Rotta, G.; Bonasio, R.; Granucci, F.; Krasehenbuhl, J.P.; Ricciardi-Castagnoli, P. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat. Immunol. 2001, 2, 361-367.
99. Jang, M.H.; Kweon, M.; Iwatani, K.; Yamamoto, M.; Terahara, K.; Sasakawa, C.; Suzuki, T.; Nochi, T.; Yokota, Y.; Rennert, P.D.; et al. Intestinal villous M cells: An antigen entry site in the mucosal epithelium. Proc. Natl. Acad. Sci. USA 2004, 101, 6110-6115.
100. Neutra, M.R.; Mantis, N.J.; Frey, A.; Giannasca, P.J. The composition and function of M cell apical membranes: Implications for microbial pathogenesis. Semin. Immunol. 1999, 11, 171-181.
101. Abreu, M. Toll-like receptor signalling in the intestinal epithelium: How bacterial recognition shapes intestinal function. Nat. Rev. Immunol. 2010, 10, 131-144.
102. Gewirtz, A.T.; Navas, T.A.; Lyons, S.; Godowski, P.J.; Madara, J.L. Cutting edge: Bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression. J. Immunol. 2001, 164, 1882-1885.
103. Rhee, S.H.; Im, E.; Riegler, M.; Kokkotou, E.; O'Brien, M.; Pothoulakis, C. Pathophysiological role of Toll-like receptor 5 engagment by bacterial flagellin in colonic inflammation. Proc. Natl. Acad. Sci. USA 2005, 102, 13610-13615.
104. Eckmann, L.; Kagnoff, M.F.; Fierer, J. Epithelial cells secrete the chemokine interleukin-8 in response to bacterial entry. Infect. Immun. 1993, 61, 4569-4574.
105. Otte, J.M.; Podolsky, D.K. Functional modulation of enterocytes by gram-positive and gram-negative microorganisms. Am. J. Physiol. Gastrointest. Liver Physiol. 2004, 286, G613-G626.
106. Barbier de La Serre, C.; Ellis, C.L.; Lee, J.; Hartman, A.L.; Rutledge, J.C.; Raybould, H.E. Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 2010, 299, G440-G448.
107. Koyama, I.; Matsunaga, T.; Harada, T.; Hokari, S.; Komoda, T. Alkaline phosphatases reduce toxicity of lipopolysaccharides in vivo and in vitro through dephosphorylation. Clin. Biochem. 2002, 35, 455-461.
108. Bates, J.M.; Akerlund, J.; Mittge, E.; Guillemin, K. Intestional alkaline phosphatase detoxifies lipopolysaccharide and prevents inflammation in response to the gut microbiota. Cell Host Microbe 2007, 2, 371-382.
109. Lee, J.; Mo, J.H.; Katakura, K.; Alkalay, I.; Rucker, A.N.; Liu, Y.T.; Lee, H.K.; Shen, C.; Cojocaru, G.; Shenouda, S.; et al. Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells. Nat. Cell Biol. 2006, 8, 1327-1336.
110. Shibolet, O.; Podolsky, D.K. TLRs in the Gut. IV. Negative regulation of Toll-like receptors and intestinal homeostasis: Addition by subtraction. Am. J. Physiol. Gastrointest. Liver Physiol. 2007, 292, G1469-G1473.
111. Rudensky, A.Y. Regulatory T-cells and Foxp3. Immunol. Rev. 2011, 241, 260-268.
112. Josefowicz, S.Z.; Lu, L.F.; Rudensky, A.Y. Regulatory T-cells: Mechanisms of differentiation and function. Annu. Rev. Immunol. 2012, 30, 364-531.
113. Lavasani, S.; Dzhambazov, B.; Nouri, M.; Fak, F.; Buske, S.; Molin, G.; Thorlacius, H.; Alenfall, J.; Jeppsson, B.; Westrom, B. A novel probiotic mixture exerts a therapeutic effect on experimental autoimmune encephalomyelitis mediated by IL-10 producing regulatory T-cells. PLoS One 2010, 5, e9009.
114. Haller, D.; Serrant, P.; Granato, D.; Schiffrin, E.J.; Blum, S. Activation of human NK cells by Staphylocci and Lactobacilli requires cell contact-dependent costimulation by autologous monocytes. Clin. Diagn. Lab. Immunol. 2002, 9, 649-657.
115. Smits, H.H.; Engering, A.; ven der Kleij, D.; de Jong, E.C.; Schipper, K.; van Capel, T.M.; Zaat, B.A.; Yazdanbakhsh, M.; Wierenga, E.A.; van Kooyk, Y.; et al. Selective probiotic bacteria induce IL-10-producing regulatory T-cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. J. Allergy Clin. Immunol. 2005, 115, 1260-1267.
116. Jeon, S.G.; Kayama, H.; Ueda, Y.; Takahashi, T.; Asahara, T.; Tsuji, H.; Tsuji, N.M.; Kiyono, H.; Ma, J.S.; Kusu, T.; et al. Probiotic Bifidobacterium breve induces IL-10 producing Tr1 cells in the colon. PLoS One 2012, 8, e1002714.
117. Peterson, E.R.; Claesson, H.; Schmidt, E.G.; Jensen, S.S.; Ravn, P.; Olsen, J.; Ouwehand, A.; Kristensen, N. Consumption of probiotics increases the effect of regulatory T-cells in transfer colitis. Inflamm. Bowel Dis. 2012, 18, 1-12.
118. Re, F.; Strominger, J.L. IL-10 released by concomitant TLR-2 stimulation blocks the induction of a subset of Th1 cytokines that are specifically induced by TLR-4 or TLR-3 in human dendritic cells. J. Immunol. 2004, 173, 7548-7555.
119. Coombes, J.L.; Siddiqui, K.R.; Arancibia-Carcamo, C.V.; Hall, J.; Sun, C.M.; Belkaid, Y.; Powrie, F. A functionally specialised population of mucosal CD103+ DCs induces Foxp3+ regulatory T-cells via a TGF-β and retinoic acid-dependent manner. J. Exp. Med. 2007, 204, 1757-1764.
120. Evrard, B.; Coudeyras, S.; Dosgilbert, A.; Charbonnel, N.; Alame, J.; Tridon, A.; Forestier, C. Dose-dependent immunomodulation of human dendritic cells by the probiotic Lactobacillus rhamnosus Lcr35. PLoS One 2011, 6, e18735.
121. Miettinen, M.; Matikainen, S.; Vuopio-Varkila, J.; Pirhonen, J.; Varkila, K.; Kurimoto, M.; Julkunen, I. Lactobacilli and streptococci induce interleukin-12 (IL-12), IL-18 and gamma interferon production in human peripheral blood mononuclear cells. Infect. Immun. 1998, 66, 6058-6062.
122. Pochard, P.; Gossett, P.; Grangette, C.; Andre, C.; Tonnel, A.; Pestel, J.; Mercenier, A. Lactic acid bacteria inhibit Th2 cytokine production by mononuclear cells from allergic patients. Basic Clin. Immunol. 2002, 110, 617-623.
123. Niers, L.E.; Timmerman, H.M.; Rijkers, G.T.; van Bleek, G.M.; van Uden, N.O.; Knol, E.F.; Kapsenberg, M.L.; Kimpen, J.L.; Hoekstra, M.O. Identification of strong interleukin-10 inducing lactic acid bacteria which down-regulate T helper type 2 cytokines. Clin. Exp. Allergy 2005, 35, 1481-1489.
124. Shida, K.; Suzuki, T.; Kiyoshima-Shibata, J.; Shimada, S.I.; Nanno, M. Essential roles of monocytes in stimulating human peripheral blood mononuclear cells with Lactobacillus casei to produce cytokines and augment natural killer cell activity. Clin. Vaccine Immunol. 2006, 13, 997-1003.
125. Takeda, K.; Suzuki, T.; Shimada, S.I.; Shida, K.; Nanno, M.; Okumura, K. Interleukin-12 is involved in the enhancement of human natural killer cell activity by Lactobacillus casei Shirota. Clin. Exp. Immunol. 2006, 146, 109-115.
126. Castellazi, A.M.; Valsecchi, C.; Montagna, L.; Malfa, P.; Ciprandi, G.; Avanzini, M.A.; Marseglia, G.L. In vitro activation of mononuclear cells by two probiotics: Lactobacillus paracasei I 1688, Lactobacillus salivarus I 1794, and their mixture (PSMIX). Immunol. Invest. 2007, 36, 413-421.
127. Medina, M.; Izquierdo, E.; Ennahar, S.; Sanz, Y. Differential immunomodulatory properties of Bifidobacterium longum strains: Relevance to probiotics selection and clinical applications. Clin. Exp. Immunol. 2007, 150, 531-538.
128. Ghadimi, D.; Folster-Holst, R.; de Vrese, M.; Winkler, P.; Heller, K.J.; Schrezenmeir, J. Effects of probiotic bacteria and their genomic DNA on TH1/TH2-cytokine production by peripheral blood mononuclear cells (PBMCs) of healthy and allergic subjects. Immunobiology 2008, 213, 677-692.
129. Dong, H.; Rowland, I.; Tuohy, K.M.; Thomas, L.V.; Yaqoob, P. Selective effects of Lactobacillus casei Shirota on T-cell activation, natural killer cell activity and cytokine production. Clin. Exp. Immunol. 2010, 161, 378-388.
130. Vissers, Y.M.; Snel, J.; Zuurendonk, P.F.; Smit, B.A.; Wichers, H.J.; Savelkoul, H.F. Differential effects of Lactobacillus acidophilus and Lactobacillus plantarum strains on cytokine induction in human peripheral blood mononuclear cells. FEMS Immunol. Med. Microbiol. 2010, 59, 60-70.
131. O'Mahony, L.; O'Callaghan, L.; McCarthy, J.; Shilling, D.; Scully, P.; Sibartie, S.; Kavanagh, E.; Kirwan, W.O.; Redmond, H.P.; Collins, J.K.; et al. Differential cytokine response from dendritic cells to commensal and pathogenic bacteria in different lymphoid compartments in humans. Am. J. Physiol. Gastrointest. Liver Physiol. 2006, 290, 839-845.
132. Fink, L.N.; Zeuthen, L.H.; Christensen, H.R.; Morandi, B.; Frokiaer, H.; Ferlazzo, G. Distinct gut-derived lactic acid bacteria elicit divergent dendritic cell-mediated NK cell responses. Int. Immunol. 2007, 19, 1319-1327.
133. Mohamadzadeh, M.; Olson, S.; Kalina, W.V.; Ruthel, G.; Demmin, G.L.; Warfield, K.L.; Bavari, S.; Klaenhammer, T.R. Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarisation. Proc. Natl. Acad. Sci. USA 2005, 102, 2880-2885.
134. Ghadimi, D.; Helwig, U.; Schrezenmeir, J.; Heller, K.J.; de Vrese, M. Epigenetic imprinting by commensal probiotics inhibits the IL-23/IL-17 axis in an in vitro model of the intestinal mucosal immune system. J. Leukoc. Biol. 2012, 92, 895-911.
135. Paolillo, R.; Carratelli, C.R.; Sorrentino, S.; Mazzola, N.; Rizzo, A. Immunomodulatory effects of Lactobacillus plantarum on human colon cancer cells. Int. Immunopharmacol. 2009, 9, 1265-1271.
136. Donkor, O.N.; Ravikumar, M.; Proudfoot, O.; Day, S.L.; Apostolopoulos, V.; Paukovics, G.; Vasiljevic, T.; Nutt, S.L.; Gill, H. Cytokine profile and induction of T helper type 17 and regulatory T cells by human peripheral mononuclear cells after microbial exposure. Clin. Exp. Immunol. 2012, 167, 282-295.
137. Haller, D.; Bode, C.; Hammes, W.P.; Pfeifer, A.M.; Schiffrin, E.J.; Blum, S. Non-pathogenic bacteria elicit a differential cytokine response by intestinal epithelial cell/leucocyte co-cultures. Gut 2000, 47, 79-87.
138. Foey, A.D. Mucosal Macrophages: Phenotypr and Functionality in Homeostasis and Pathology. In Handbook of Macrophages: Life Cycle, Functions and Diseases; Takahashi, R., Kai, H., Eds.; Nova Science Publishers Inc.: New York, NY, USA, 2012; Chapter 4, pp. 121-146.
139. Habil, N.; Al-Murrani, W.; Beal, J.; Foey, A.D. Probiotic bacterial strains differentially modulate macrophage cytokine production in a strain-dependent and cell subset-specific manner. Benef. Microbes 2011, 2, 283-293.
140. Habil, N.; Beal, J.; Foey, A. Lactobacillus casei strain Shirota selectively modulates macrophage subset cytokine production. Int. J. Probiotics Prebiotics 2012, 7, 1-12.
141. Foey, A.D. Butyrate regulation of distinct macrophage subsets: Opposing effects on M1 and M2 macrophages. Int. J. Probiotics Prebiotics 2011, 6, 147-158.
142. Helwig, U.; Lammers, K.M.; Rizzello, F.; Brigidi, P.; Rohleder, V.; Caramelli, E.; Gionchetti, P.; Schrezenmeir, J.; Foelsch, U.R.; Schreiber, S.; et al. Lactobacilli, bifidobacteria and E. coli Nissle induce pro- and anti-inflammatory cytokines in peripheral blood mononuclear cells. World J. Gastroenterol. 2006, 12, 5978-5986.
143. Perez-Cano, F.J.; Dong, H.; Yaqoob, P. In vitro immunomodulatory activity of Lactobacillus fermentum CECT5716 and Lactobacillus salivarius CECT5713: Two probiotic strains isolated from human breast milk. Immunobiology 2010, 215, 996-1004.
144. Thomas, C.M.; Hong, T.; van Pijkeren, J.P.; Hemarajata, P.; Trinh, D.V.; Hu, W.; Britton, R.A.; Kalkum, M.; Versalovic, J. Histamine derived from probiotic Lactobacillus reuteri suppresses TNF via modulation of PKA and ERK signalling. PLoS One 2012, 7, e31951.
145. Ruiz, P.A.; Hoffmann, M.; Szcesny, S.; Blaut, M.; Haller, D. Innate mechanisms for Bifidobacterium lactis to activate transient pro-inflammatory host responses in intestinal epithelial cells after the colonisation of germ-free rats. Immunology 2005, 115, 441-450.
146. Vinderola, G.; Matar, C.; Perdigon, G. Role of intestinal epitelial cells in immune effects mediated by gram-positive probiotic bactéria: Involvement of toll-like receptors. Clin. Diagn. Lab. Immunol. 2005, 12, 1075-1084.
147. Hart, A.L.; Lammers, K.; Brigidi, P.; Vitali, B.; Rizzello, F.; Gionchetti, P.; Campieri, M.; Kamm, M.A.; Knight, S.C.; Stagg, A.J. Modulation of human dendritic cell phenotype and function by probiotic bacteria. Gut 2004, 53, 1602-1609.
148. Braat, H.; van den Brande, J.; van Tol, E.; Hommes, D.; Peppelenbosch, M.; van Deventer, S. Lactobacillus rhamnosus induces peripheral hyporesponsiveness in stimulated CD4+ Tcells via modulation of dendritic cell function. Am. J. Nutr. 2004, 80, 1618-1625.
149. Latvala, S.; Pietila, T.E.; Veckman, V.; Kekkonen, R.A.; Tynkknen, S.; Korpela, R.; Julkunen, I. Potentially probiotic bacteria induce efficient maturation but differential cytokine production in human monocyte-derived dendritic cells. World J. Gastroenterol. 2008, 14, 5570-5583.
150. Koniecza, P.; Groeger, D.; Ziegler, M.; Frei, R.; Ferstl, R.; Shanahan, F.; Quigley, E.M.; Kiely, B.; Akdis, C.A.; O'Mahony, L. Bifidobacterium infantis 35624 administration induces Foxp3 T regulatory cells in human peripheral blood: Potential role for myeloid and plasmacytoid dendritic cells. Gut 2012, 61, 354-366.
151. Strober, W.; Zhang, F.; Kitani, A.; Fuss, I.; Fichtner-Feigl, S. Proinflammatory cytokines underlying the inflammation of Crohn's disease. Curr. Opin. Gastroenterol. 2010, 26, 307-310.
152. Chen, Z.; O'Shea, J.J. Regulation of IL-17 production in human lymphocytes. Cytokine 2008, 41, 71-78.
153. Cooke, A. Th17 cells in inflammatory conditions. Rev. Diabet. Stud. 2006, 3, 72-75.
154. Dicksved, J.; Halfvarson, J.; Rosenquist, M.; Jarnernot, G.; Tysk, C.; Apajalahti, J.; Engstrand, L.; Jansson, J.K. Molecular analysis of the gut microbiota of identical twins with Crohn's disease. ISME 2008, 2, 716-727.
155. Erickson, A.R.; Cantarel, B.L.; Lamendella, R.; Darzi, Y.; Mongodin, E.F.; Pan, C.; Shah, M.; Halfvarson, J.; Tysk, C.; Henrissat, B.; et al. Integrated metagenomics/metaproteomics reveals human host-micrbiota signatures of Crohns' disease. PLoS One 2012, 7, e49138.
156. Maeda, S.; Hsu, L.C.; Liu, H.; Bankston, L.A.; Limura, M.; Kagnoff, M.F.; Eckmann, L.; Karin, M. Nod2 mutation in Crohn's disease potentiates NF-κB activity and IL-1β processing. Science 2006, 307, 734-738.
157. Hong, J.; Leung, E.; Fraser, A.G.; Merriman, T.R.; Vishnu, P.; Krissansen, G.W. TLR2, TLR4 and TLR9 polymorphisms and Crohn's disease in a New Zealand Caucasian cohort. J. Gastroenterol. Hepatol. 2006, 22, 1760-1766.
158. Hugot, J. CARD15/NOD2 mutations in Crohn's disease. Ann. N. Y. Acad. Sci. 2006, 1072, 9-18.
159. Netea, M.G.; Kullberg, B.J.; de Jong, D.J.; Franke, B.; Sprong, T.; Naber, T.H.J.; Drenth, J.P.H.; van der Meer, J.W. NOD2 mediates anti-inflammatory signals induced by TLR2 ligands: Implications for Crohn's disease. Eur. J. Immunol. 2004, 34, 2052-2059.
160. Sokol, H.; Pigneur, B.; Watterlot, L.; Lakhdari, O.; Bermudez-Humaran, L.G.; Gratadoux, J.J.; Blugeon, S.; Bridonneau, C.; Furet, J.P.; Corthier, G.; et al. Feacalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Natl. Acad. Sci. USA 2008, 105, 16731-16736.
161. Jia, W.; Whitehead, R.N.; Griffiths, L.; Dawson, C.; Waring, R.H.; Ramsden, D.B.; Hunter, J.O.; Cole, J.A. Is the abundance of Faecalibacterium prausnitzii relevant to Crohn's disease? FEMS Microbiol. Lett. 2010, 310, 138-144.
162. Van Immerseel, F.; Ducatelle, R.; de Vos, M.; Boon, N.; van de Wiele, T.; Verbeke, K.; Rutgeerts, P.; Sas, B.; Louis, P.; Flint, H.J. Butyric acid-producing anaerobic bacteria as a novel probiotic treatment approach for inflammatory bowel disease. J. Med. Microbiol. 2010, 59, 141-143.
163. Duncan, S.H.; Hold, G.L.; Harmsen, H.J.M.; Stewart, C.S.; Flint, H.J. Growth requirements and fermentation products of Fusobacterium prausnitzii, and a proposal to reclassify it as Faecalibacterium prausnitzii gen. nov., comb. nov. Int. J. Syst. Evol. Microbiol. 2002, 52, 2141-2146.
164. Pryde, S.E.; Duncan, S.H.; Hold, G.L.; Stewart, C.S.; Flint, H.J. The microbiology of butyrate formation in the human colon. FEMS Micrbiol. Lett. 2002, 217, 133-139.
165. Tuohy, K.M.; Rouzaud, G.C.M.; Bruck, W.M.; Gibson, G.R. Modulation of the human gut microflora towards improved health using prebiotics-assessment of efficacy. Curr. Pharm. Des. 2005, 11, 75-90.
166. Ramirez-Farias, C.; Slezak, K.; Fuller, Z.; Duncan, A.; Holtrop, G.; Louis, P. Effect of inulin on the human gut microbiota: Stimulation of Bifidobacterium adolescentis and Faecalibacterium prausnitzii. Br. J. Nutr. 2009, 101, 541-550.
167. Benjamin, J.L.; Hedin, C.R.H.; Koutsoumpas, A.; Ng, S.C.; McCarthy, N.E.; Hart, A.L.; Kamm, M.A.; Sanderson, J.D.; Knight, S.C.; Forbes, A.; et al. Randomised, double-blind, placebo-controlled trail of fructo-oligosaccharides in active Crohn's disease. Gut 2011, 60, 923-929.
168. Schultz, M.; Veltkamp, C.; Dieleman, L.A.; Grenther, W.B.; Wyrick, P.B.; Tonkonogy, S.L.; Sartor, R.B. Lactobacillus plantarum 299v in the treatment and prevention of spontaneous colitis in interleukin-10-deficient mice. Inflamm. Bowel Dis. 2002, 8, 71-80.
169. Dieleman, L.A.; Goerres, M.S.; Arends, A.; Sprengers, D.; Torrice, C.; Hoentjen, F.; Grenther, W.B.; Sartor, R.B. Lactobacillus GG prevents recurrence of colitis in HLA-B27 transgenic rats after antibiotic treatment. Gut 2003, 52, 370-376.
170. Furrie, E.; Macfarlane, S.; Kennedy, A.; Cummings, J.H.; Walsh, S.V.; O'Neil, D.A.; Macfarlane, G.T. Synbiotic therapy (Bifidobacterium longum/Synergy1) initiates resolution of inflammation in patients with active ulcerative colitis: A randomised controlled pilot trial. Gut 2005, 54, 242-249.
171. Fujimori, S.; Gudis, K.; Mitsui, K.; Seo, T.; Yonezawa, M.; Tanaka, S.; Tatsuguchi, A.; Sakamoto, C. A randomized controlled trial on the efficacy of synbiotic versus probiotic and prebiotic treatment to improve the quality of life in patients with ulcerative colitis. Nutrition 2009, 25, 520-525.
172. Mennigen, R.; Nolte, K.; Rijcken, E.; Utech, M.; Loeffler, B.; Senninger, N.; Bruewer, M. Probiotic mixture VSL#3 protects the epithelial barrier by maintaining tight junction protein expression and preventing apoptosis in a murine model of colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 2009, 296, 1140-1149.
173. Miele, E.; Pascarella, F.; Giannetti, E.; Quaglietta, L.; Baldassano, R.N.; Staiano, A. Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis. Am. J. Gastroenterol. 2009, 104, 437-443.
174. Uronis, J.M.; Arthur, J.C.; Keku, T.; Fodor, A.; Carroll, I.M.; Cruz, M.L.; Appleyard, C.B.; Jobin, C. Gut microbial diversity is reduced by the probiotic VSL#3 and correlates with decreased TNBS-induced colitis. Inflamm. Bowel Dis. 2011, 17, 289-297.
175. Rowland, I.R.; Rumney, C.J.; Coutts, J.T.; Lievense, L.C. Effect of Bifidobacterium longum and inulin on gut bacterial metabolism and carcinogen-induced aberrant crypt foci in rats. Carcinogenesis 1998, 19, 281-285.
176. Femia, A.P.; Luceri, C.; Dolara, P.; Giannini, A.; Biggeri, A.; Salvadori, M.; Clune, Y.; Collins, K.J.; Paglierani, M.; Caderni, G. Antitumorigenic activity of the prebiotic inulin enriched with oligofructose in combination with the prebiotics Lactobacillus rhamnosus and Bifidobacterium lactis in azoxymethane-induced colon carcinogenesis in rats. Carcinogenesis 2002, 23, 1953-1960.
177. Moreno de LeBlanc, A.; Matar, C.; Perdigon, G. The application of probiotics in cancer. Br. J. Nutr. 2007, 98, 105-110.
178. Rafter, J.; Bennett, M.; Caderni, G.; Clune, Y.; Hughes, R.; Karlsson, P.C.; Klinder, A.; O'Riordan, M.; O'Sullivan, G.C.; Pool-Zobel, B.; et al. Dietary synbiotics reduce cancer risk factors in polypectomised and colon cancer patients. Am. J. Clin. Nutr. 2007, 85, 488-496.
179. Bassaganya-Riera, J.; Viladomiu, M.; Pedragosa, M.; de Simone, C.; Carbo, A.; Shaykhutdinov, R.; Jobin, C.; Arthur, J.C.; Corl, B.A.; Vogel, H.; et al. Probiotic bacteria produce conjugated linoleic acid locally in the gut that targets macrophage PPAR-gamma to suppress colitis. PLoS One 2012, 7, e31238.
180. Chen, C.C.; Lin, W.C.; Kong, M.S.; Shi, H.N.; Walker, W.A.; Lin, C.Y.; Huang, C.T.; Lin, Y.C.; Jung, S.M.; Lin, T.Y. Oral inoculation of probiotics Lactobacillus acidophilus NCFM suppresses tumour growth both in segmental orthotopic colon cancer and extra-intestinal tissue. Br. J. Nutr. 2012, 107, 1623-1634.
181. Repa, A.; Grangette, C.; Daniel, C.; Hochreiter, R.; Hoffmann-Sommergruber, K.; Thlhamer, J.; Kraft, D.; Breiteneder, H.; Mercenier, A.; Wiedermann, U. Mucosal co-application of lactic acid bacteria and allergen induces counter-regulatory immune responses in a murine model of birch pollen allergy. Vaccine 2003, 22, 87-95.
182. Van de Pol, M.A.; Lutter, R.; Smids, B.S.; Weersink, E.J.M.; van der Zee, J.S. Synbiotics reduce allergen-induced T-helper 2 response and improve peak expiratory flow in allergic asthmatics. Allergy 2010, 66, 39-47.
183. Van der Aa, L.B.; Lutter, R.; Heymans, H.S.; Smids, B.S.; Dekker, T.; van Aalderen, W.M.; Sillevis Smitt, J.H.; Knippels, L.M.J.; Garssen, J.; Nauta, A.J.; et al. No detectable beneficial systemic immunomodulatory effects of a specific synbiotic mixture in infants with atopic dermatitis. Clin. Exp. Allergy 2012, 42, 531-539.
184. Van der Aa, L.B.; Heymans, H.S.; van Aalderen, W.M.; Sillevis Smitt, J.H.; Knol, J.; Ben Amor, K.; Goossens, D.A.; Sprikkelman, A.B.; Synbad Study Group. Effect of a new synbiotic mixture on atopic dermatitis in infants: A randomised-controlled trial. Clin. Exp. Allergy 2010, 40, 795-804.
185. D'Arienzo, R.; Maurano, F.; Luongo, D.; Mazzarella, G.; Stefanile, R.; Troncone, R.; Auricchio, S.; Ricca, E.; David, C.; Rossi, M. Adjuvant effect of Lactobacillus casei in a mouse model of gluten sensitivity. Immunol. Lett. 2008, 119, 78-83.
186. Lindfors, K.; Blomqvist, T.; Juuti-Uusitalo, K.; Stenman, S.; Venalainen, J.; Maki, M.; Kaukinen, K. Live probiotic Bifidobacterium lactis bacteria inhibit the toxic effects induced by wheat gliadin in epithelial cell culture. Clin. Exp. Immunol. 2008, 152, 552-558.
187. De Palma, G.; Cinova, J.; Stepankova, R.; Tuckova, L.; Sanz, Y. Pivotal advance: Bifidobacteria and Gram-negative bacteria differentially influence immune responses in the proinflammatory milieu of celiac disease. J. Leukoc. Biol. 2010, 87, 765-778.
188. D'Arienzo, R.; Maurano, F.; Lavermicocca, P.; Ricca, E.; Rossi, M. Modulation of the immune response by probiotic strains in a mouse model of gluten sensitivity. Cytokine 2009, 48, 254-259.
189. Kullberg, M.C.; Jankovic, D.; Feng, C.G.; Hue, S.; Gorelick, P.L.; McKenzie, B.S.; Cua, D.J.; Powrie, F.; Cheever, A.W.; Maloy; et al. IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis. J. Exp. Med. 2006, 203, 2485-2494.
190. Brand, S. Crohn's disease: Th1, Th17 or both? The change of a paradigm: New immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease. Gut 2009, 58, 1152-1167.
191. Fujimori, S.; Tatsuguchi, A.; Gudis, K.; Kishida, T.; Mitsui, K.; Ehara, A.; Kobayashi, T.; Sekita, Y.; Seo, T.; Sakamoto, C. High dose probiotic and prebiotic cotherapy for the remission induction of active Crohn's disease. J. Gastroenterol. Hepatol. 2006, 22, 1199-1204.
192. Popivanova, B.K.; Kitamura, K.; Wu, Y.; Kondo, T.; Kagaya, T.; Kaneko, S.; Oshima, M.; Fuji, C.; Mukaida, N. Blocking TNF-α in mice reduces colorectal carcinogenesis associated with chronic colitis. J. Clin. Invest. 2008, 118, 560-570.
193. Gophna, U.; Sommerfeld, K.; Gophna, S.; Doolittle, W.F.; Veldhuyzen van Zanten, S.J. Differences between tissue-associated intestinal microfloras of patients with Crohn's disease and Ulcerative colitis. J. Clin. Microbiol. 2006, 44, 4136-4141.
194. Sood, A.; Midha, V.; Makharia, G.K.; Ahuja, V.; Singal, D.; Goswami, P.; Tandon, R.K. The probiotic preparation, VSL#3, induces remission in patients with mild-to-moderately active ulcerative colitis. Clin. Gastroenterol. Heptol. 2009, 7, 1202-1209.
195. Henriksen, M.; Jahnsen, J.; Lygren, I.; Stray, N.; Sauar, J.; Vatn, M.H.; Moum, B.; IBSEN Study Group. C-reactive protein: A predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study. Gut 2008, 57, 1518-1523.
196. Rizello, V.; Bonaccorsi, I.; Dongarra, M.L.; Fink, L.N.; Ferlazzo, G. Role of natural killer and dendritic cell crosstalk in immunomodulation by commensal bacteria probiotics. J. Biomed. Biotechnol. 2011, 2011, 1-10.
197. Szaradkiewicz, A.; Marciniak, R.; Chudzicka-Strugala, I.; Wasilewska, A.; Drews, M.; Majewski, P.; Karpinski, T.; Zwozdziak, B. Proinflammatory cytokines and IL-10 in inflammatory bowel disease and colorectal cancer patients. Arch. Immunol. Ther. Exp. 2009, 57, 291-294.
198. Kane, K.F.; Langman, M.J.; Williams, G.R. Antiproliferative responses of two human colon cancer cell lines to Vitamin D3 are differentially modified by 9-cis-retionic acid. Cancer Res. 1996, 56, 623-632.
199. Muscat, J.; Wynder, E.L. The consumption of well-done red meat and the risk of colorectal cancer. Am. J. Public Health 1994, 84, 856-858.
200. Le Marchand, L.; Hankin, J.H.; Wilkens, L.R.; Pierce, L.M.; Franke, A.; Kolonel, L.N.; Seifried, A.; Custer, L.J.; Chang, W.; Lum-Jones, A.; et al. Combined effects of well-done red meat, smoking and rapid N-acetyltransferase 2 and CYP1A2 phenotypes in increasing colorectal cancer risk. Cancer Epidemiol. Biomarkers Prev. 2001, 10, 1259-1266.
201. Herbst, T.; Sichelstiel, A.; Schär, C.; Yadava, K.; Bürki, K.; Cahenzli, J.; McCoy, K.; Marsland, B.J.; Harris, N.L. Dysregulation of allergic airway inflammation in the absence of microbial colonization. Am. J. Respir. Crit. Care Med. 2011 184, 198-205.
202. Abrahamsson, T.R.; Jakobsson, H.E.; Andersson, A.F.; Björkstén, B.; Engstrand, L.; Jenmalm, M.C. Low diversity of the gut microbiota in infants with atopic eczema. J. Allery Clin. Immun. 2012, 129, 434-440.
203. Nylund, L.; Satokari, R.; Nikkilä, J.; Rajilić-Stojanović, M.; Kalliomäki, M.; Isolauri, E.; Salminen, S.; de Vos, W.M. Microarray analysis reveals marked intestinal microbiota aberrancy in infants having eczema compared to healthy children in at-risk for atopic disease. BMC Microbiol. 2013, 13, 12.
204. Lee, H.; Kim, H.; Lee, E.; Jang, M.; Kim, S.; Park, J.; Seoh, J.; Jung, Y. Characterisation of CCR9 expression and thymus-expressed chemokine responsiveness of the murine thymus, spleen and mesenteric lymph nodes. Immunobiology 2012, 217, 402-411.
205. Kalliomäki, M.; Salminen, S.; Arvilommi, H.; Kero, P.; Koskinen, P.; Isolauri, E. Probiotics in primary prevention of atopic disease: A randomised placebo-controlled trial. Lancet 2001, 357, 1076-1079.
206. Böttcher, M.F.; Nordin, E.K.; Sandin, A.; Midtvedt, T.; Björkstén, B. Microflora-associated characteristics in faeces from allergic and nonallergic infants. Clin. Exp. Allergy 2000, 30, 1590-1596.
207. Wakabayashi, H.; Nariai, C.; Takemura, G.; Nakao, W.; Fujiwara, D. Dietary supplementation with lactic acid bacteria attenuates the development of atopic-dermatitis-like skin lesions in NC/Nga mice in a strain-dependent manner. Int. Arch. Allergy Immunol. 2008, 145, 141-151.
208. Tanaka, A.; Jung, K.; Benyacoub, J.; Prioult, G.; Okamoto, N.; Ohmori, K.; Blum, S.; Mercenier, A.; Mastuda, H. Oral supplementation with Lactobacillus rhamnosus CGMCC 1.3724 prevents development of atopic dermatitis in NC/NgaTnd mice possibly by modulating local production of IFN-gamma. Exp. Dermatol. 2009, 18, 1022-1027.
209. Brouwer, M.L.; Wolt-Plompen, S.A.; Dubois, A.E.; van der Heide, S.; Jansen, D.F.; Hoijer, M.A.; Kauffman, H.F.; Duiverman, E.J. No effects of probiotics on atopic dermatitis in infancy: A randomized placebo-controlled trial. Clin. Exp. Allergy 2006, 36, 899-906.
210. Tanaka, A.; Fukushima, Y.; Bevacoub, J.; Blum, S.; Matsuda, H. Prophylactic effect of oral administration of Lactobacillus johnsonii NCC533 (La1) during the weaning period on atopic dermatitis in NC/NgaTnd mice. Eur. J. Dermatol. 2008, 18, 136-140.
211. Inoue, R.; Nishio, A.; Fukushima, Y.; Ushida, K. Oral treatment with probiotic Lactobacillus johnsonii NCC533 (La1) for a specific part of the weaning period prevents the development of atopic dermatitis induced after maturation in model mice, NC/Nga. Br. J. Dermatol. 2007, 156, 499-509.
212. Wickens, K.; Black, P.; Stanley, T.V.; Mitchell, E.; Fitzharris, P.; Tannock, G.W.; Purdie, G.; Crane, J.; Probiotic Study Group. A differential effect of 2 probiotics in the prevention of eczema and atopy: A double-blind, randomized, placebo controlled trial. J. Allergy Clin. Immunol. 2008, 122, 788-794.
213. Wickens, K.; Black, P.; Stanley, T.V.; Mitchell, E.; Barthow, C.; Fitzharris, P.; Purdie, G.; Crane, J. A protective effect of Lactobacillus rhamnosus HN001 against eczema in the first 2 years of life persists to age 4 years. Clin. Exp. Allergy 2012, 42, 1071-1079.
214. Shah, M.M.; Saio, M.; Yamashita, H.; Tanaka, H.; Takami, T.; Ezaki, T.; Inagaki, N. Lactobacillus acidophilus strain L-92 induces CD4+ CD25+ Foxp3+ regulatory T cells and suppresses allergic contact dermatitis. Biol. Pharm. Bull. 2012, 35, 612-616.
215. Karimi, K.; Inman, M.D.; Bienenstock, J.; Forsythe, P. Lactobacillus reuteri-induced regulatory T cells protect against an allergic airway response in mice. Am. J. Respir. Crit. Care Med. 2009, 197, 186-193.
216. + T-cells by probiotics administration suppresses immune disorders. Proc. Natl. Acad. Sci. USA 2010, 107, 2159-2164.
217. Shida, K.; Takahashi, E.; Iwadate, E.; Takamizawa, K.; Yasui, H.; Sato, T.; Habu, S.; Hachimura, S.; Kaminogawa, S. Lactobacillus casei strain Shirota suppresses serum immunoglobulin E and immunoglobulin G1 responses and systemic anaphylaxis in a food allergy model. Clin. Exp. Allergy 2002, 32, 563-570.
218. Takahashi, N.; Kitazawa, H.; Iwabuchi, N.; Xiao, J.Z.; Miyaji, K.; Iwatsuki, K.; Saito, T. Immunostimulatory oligodeoxynucleotide from Bifidobacterium longum suppresses Th2 immune responses in a murine model. Clin. Exp. Immunol. 2006, 145, 130-138.
219. Schiffer, C.; Lalanne, A.I.; Cassard, L.; Mancardi, D.A.; Malbec, O.; Bruhns, P.; Dif, F.; Daeron, M. A strain of Lactobacillus casei inhibits the effector phase of immune inflammation. J. Immunol. 2011, 187, 1-10.
220. Dev, S.; Mizuguchi, H.; Das, A.K.; Matsushita, C.; Maeyama, K.; Umehara, H.; Ohtoshi, T.; Kojima, J.; Nishida, K.; Takahashi, K.; et al. Suppression of histamine signalling by probiotic Lac-B: A possible mechanism of its anti-allergic effect. J. Pharmacol. Sci. 2008, 107, 159-166.
221. Van Heel, D.A.; West, J. Recent advances in coeliac disease. Gut 2006, 55, 1037-1046.
222. Jabri, B.; Patey-Mariaud De Seery, N.; Cellier, C.; Evans, K.; Gache, C.; Carvalho, C.; Mougenot, J.F.; Allez, M.; Jian, R.; Desreumaux, P.; et al. Selectivr expanision of intraepithelial lymphocytes expressing the HLA-E-specific natural killer receptor CD94 in celiac disease. Gastroenterology 2000, 118, 867-879.
223. Maiuri, L.; Ciacci, C.; Vacca, L.; Ricciardelli, I.; Auricchio, S.; Quaratino, S.; Londei, M. IL-15 drives the specific migration of CD94+ and TCR-γδ+ intraepithelial lymphocytes in organ cultures of treated celiac patients IL-15 and Intraepithelial Migration of CD3 γδand CD94. Am. J. Gastroenterol. 2001, 96, 150-156.
224. Meresse, B.; Chen, Z.; Ciszewski, C.; Tretiakova, M.; Bhagat, G.; Krausz, T.N.; Raulet, D.H.; Lanier, L.L.; Groh, V.; Spies, T.; et al. Coordinated induction of IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 2004, 21, 357-366.
225. Groh, V.; Steinle, A.; Bauer, S.; Spies, T. Recognition of stress-induced MHC molecules by intestinal epithelial γδ T cells. Science 1998, 279, 1737-1740.
226. Bauer, S.; Groh, V.; Wu, J.; Steinle, A.; Phillips, J.H.; Lanier, L.L.; Spies, T. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 1999, 285, 727-729.
227. Hüe, S.; Mention, J.J.; Monteiro, R.C.; Zhang, S.; Cellier, C.; Schmitz, J.; Verkarre, V.; Fodil, N.; Bahram, S.; Cerf-Bensussan, N.; et al. A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. Immunity 2004, 21, 367-377.
228. Salvati, V.M.; MacDonald, T.T.; Bajaj-Elliott, M.; Borrelli, M.; Staiano, A.; Auricchio, S.; Troncone, R.; Monteleone, G. Interleukin 18 and associated markers of T helper cell type 1 activity in coeliac disease. Gut 2002, 50, 186-190.
229. Matysiakb, T.; Moura, I.C.; Arcos-Fajardo, M.; Lebreton, C.; Menard, S.; Candalh, C.; Ben-Khalifa, K.; Dugave, C.; Tamouza, H.; van Niel, G.; et al. Sectretory IgA mediates retrotranscytosis of intact gliadin peptides via the transferrin receptor in celiac disease. J. Exp. Med. 2007, 205, 143-154.
230. Dieterich, W.; Ehnis, T.; Bauer, M.; Donner, P.; Volta, U.; Riecken, E.O.; Schuppan, D. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat. Med. 1997, 3, 797-801.
231. Dahldom, I.; Korponay-Szabo, I.R.; Kovacs, J.B.; Szalai, Z.; Maki, M.; Hansson, T. Prediction of clinical and mucosal severity of coeliac disease and dermatitis herpetiformis by quantification of IgA/IgG serum antibodies to tissue transglutaminase. J. Pediatr. Gastroenterol. Nutr. 2010, 50, 140-146.
232. Sanz, Y.; Sanchez, E.; Marzotto, M.; Calabuig, M.; Torriani, S.; Dellaglio, F. Differences in faecal bacterial communities in coeliac and healthy children as detected by PCR and denaturing gradient gel electrophoresis. FEMS Immunol. Med. Microbiol. 2007, 51, 562-568.
233. Collado, M.; Donat, E.; Ribes-Koninckx, C.; Calabuig, M.; Sanz, Y. Imbalances in faecal and duodenal Bifidobacterium species composition in active and non-active coeliac disease. BMC Microbiol. 2008, 8, 1-9.
234. Silano, M.; Agostoni, C.; Guandalini, S. Effect of the timing of gluten introduction on the development of celiac disease. World J. Gastroenterol. 2010, 16, 1939-1942.
235. D'Arienzo, R.; Stefanile, R.; Maurano, F.; Mazzarella, G.; Ricca, E.; Troncone, R.; Auricchio, S.; Rossi, M. Immunomodulatory effects of Lactobacillus casei administration in a mouse model of gliadin-sensitive enteropathy. Basic Immunol. 2011, 74, 335-341.
236. Krupa-Kozak, U.; Altamirano-Fortoul, R.; Wronkowska, M.; Rosell, C.M. Breadmaking performance and technological characteristic of gluten-free bread with inulin supplemented with calcium salts. Eur. Food Res. Technol. 2012, 235, 545-554.
237. Czesnikiewicz-Guzik, M.; Lee, W.-W.; Cui, D.; Hiruma, Y.; Lamar, D.L.; Yang, Z.-Z.; Ouslander, J.G.; Weyand, C.M.; Goronzy, J.J. T cell subset-specific susceptibility to aging. Clin. Immunol. 2008, 127, 107-118.
238. Zhang, Y.; Wallace, D.L.; de Lara, C.M.; Ghattas, H.; Asquith, B.; Worth, A.; Griffin, G.E.; Taylor, G.P.; Tough, D.F.; Beverley, P.C.; et al. In vivo kinetics of human natural killer cells: The effects of ageing and acute and chronic viral infection. Immunology 2007, 121, 258-265.
239. Dong, H.; Rowland, I.; Thomas, L.V.; Yaqoob, P. Immunomodulatory effects of a probiotic drink containing Lactobacillus casei Shirota in healthy older volunteers. Eur. J. Nutr. 2013, doi:10.1007/s00394-012-0487-1.
240. Kim, H.G.; Lee, S.Y.; Kim, N.R.; Ko, M.Y.; Lee, J.M.; Yi, T.H.; Chung, S.K.; Chung, D.K. Inhibitory effects of Lactobacillus plantarum Lipoteichoic acid (LTA) on Staphylococcus aureus LTA-induced tumour necrosis factor-alpha production. J. Microbiol. Biotechnol. 2008, 18, 1191-1196.
241. Kim, H.G.; Lee, S.Y.; Kim, N.R.; Lee, H.Y.; Ko, M.Y.; Jung, B.J.; Kim, C.M.; Lee, J.M.; Park, J.H.; Han, S.H.; Chung, D.K. Lactobacillus plantarum lipoteichoic acid down regulated Shigella flexneri peptidoglycan-induced inflammation. Mol. Immunol. 2011, 48, 291-382.
242. Kleerebezem, M.; Hols, P.; Bernard, E.; Rolain, T.; Zhou, M.; Siezen, R.J.; Bron, P.A. The extracellular biology of the lactobacilli. FEMS Microbiol. Rev. 2010, 34, 199-230.
243. Preidis, G.A.; Versalovic, J. Targeting the human microbiome with antibiotics, probiotics and prebiotics: Gastroenterology enters the metagenomics era. Gastroenterology 2009, 136, 2015-2031.
244. Yatsunenko, T.; Rey, F.E.; Manary, M.J.; Trehan, I.; Dominguez-Bello, M.G.; Contreras, M.; Magris, M.; Hidalgo, G.; Baldassano, R.N.; Anokhin, A.P.; et al. Human gut microbiome viewed across age and geography. Nature 2012, 9, 222-227.
245. Anderson, J.L.; Edney, R.J.; Whelan, K. Systematic review: Faecal microbiota transplantation in the management of inflammatory bowel disease. Aliment. Pharmacol. Ther. 2012, 36, 503-516.